Skip to main content
SpringerLink
Log in

Development of sustained-release formulations processed by hot-melt extrusion by using a quality-by-design approach

  • Research Article
  • Published:
Drug Delivery and Translational Research Aims and scope Submit manuscript

Abstract

In this study, a quality-by-design (QbD) approach was used to optimize the development of paracetamol (PMOL) sustained-release formulations manufactured by hot-melt extrusion (HME). For the purpose of the study, in-line near-infrared (NIR) spectroscopy as a process analytical technology (PAT) was explored while a design of experiment (DoE) was implemented to assess the effect of the process critical parameters and to identify the critical quality attributes (CQA) of the extrusion processing. Blends of paracetamol, ethyl cellulose (EC) and Compritol® 888 ATO (C888) were processed using a twin screw extruder to investigate the effect of screw speed, feed rate and drug loading on the dissolution rates and particle size distribution. The principal component analysis (PCA) of the NIR collected signal revealed the optimum extrusion processing parameters. Furthermore, the integration of the DoE experiments demonstrated that drug loading has a significant effect on the only quality attribute, which was the PMOL dissolution rate. This QbD approach was employed as a paradigm for the development of pharmaceutical formulations via HME processing

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11

Similar content being viewed by others

References

  1. Gavin PA, David SJ, Osama AD, Daniel NM, Mark SMc. Hot-melt extrusion: an emerging drug delivery technology. Pharm Technol Eur. 2009;2(1)

  2. Maniruzzaman M, Boateng JS, Snowden MJ, Douroumis D. A review of hot-melt extrusion: process technology to pharmaceutical products. IRRN Pharm. 2012;2012:436763.

    Google Scholar 

  3. Maniruzzaman M, Boateng JS, Bonnefille M, Aranyos A, Mitchell JC, Douroumis D. Taste masking of paracetamol by hot-melt extrusion: an in vitro and in vivo evaluation. Eur J Pharm Biopharm. 2012;80(2):433–42.

    Article  CAS  PubMed  Google Scholar 

  4. Cilurzo F, Cupone IE, Minghetti P, Selmin F, Montanari L. Fast dissolving film made of maltodextrins. Eur J Pharm Biopharm. 2008;70(3):895–900.

    Article  CAS  PubMed  Google Scholar 

  5. Kalivoda A, Fischbach M, Kleinebudde P. Application of mixtures of polymeric carriers for dissolution enhancement of fenofibrate using hot-melt extrusion. Int J Pharm. 2012;429(1–2):58–68.

    Article  CAS  PubMed  Google Scholar 

  6. De Brabander C, Vervaet C, Remon JP. Development and evaluation of sustained release mini-matrices prepared via hot melt extrusion. J Control Release. 2003;89:235–47.

    Article  PubMed  Google Scholar 

  7. Roblegg E, Jäger E, Hodzic A, Koscher G, Mohr S, Zimmer A, et al. Development of sustained-release lipophilic calcium stearate pellets via hot melt extrusion. Eur J Pharm Biopharm. 2011;79:635–45.

    Article  CAS  PubMed  Google Scholar 

  8. Almeida A, Possemiers S, Boone MN, De Beer T, Quinten T, Van Hoorebeke L. Ethylene vinyl acetate as matrix for oral sustained release dosage forms produced via hot-melt extrusion. Eur J Pharm Biopharm. 2011;77(2):297–305.

    Article  CAS  PubMed  Google Scholar 

  9. ICH. International Conference on Harmonisation (ICH) of technical requirements for registration of pharmaceuticals for human use, Topic Q8 (R2): Pharmaceutical development, Geneva, 2009.

  10. ICH. International Conference on Harmonisation (ICH) of technical requirements for registration of pharmaceuticals for human use, Topic Q9: Pharmaceutical quality system, Geneva, 2005.

  11. International Conference on Harmonisation (ICH) of technical requirements for registration of pharmaceuticals for human use, Topic Q10: Pharmaceutical quality system, Geneva, 2008.

  12. Yu LX. Pharmaceutical quality by design: product and process development, understanding, and control. Pharm Res. 2008;25(4):781–91.

    Article  CAS  PubMed  Google Scholar 

  13. Fonteyne M, Soares S, Vercruysse J, Peeters E, Burggraeve A, Vervaet C, et al. Prediction of quality attributes of continuously produced granules using complementary PAT tools. Eur J Pharm Biopharm. 2012;82(2):429–36.

    Article  CAS  PubMed  Google Scholar 

  14. Wu H, White M, Khan MA. Quality-by-design (QbD): an integrated process analytical technology (PAT) approach for a dynamic pharmaceutical co-precipitation process characterization and process design space development. Int J Pharm. 2011;405(1–2):63–78.

    Article  CAS  PubMed  Google Scholar 

  15. Adam S, Suzzi D, Radeke C, Khinast JG. An integrated quality by design (QbD) approach towards design space definition of a blending unit operation by discrete element method (DEM) simulation. Eur J Pharm Sci. 2011;42(1–2):106–15.

    Article  CAS  PubMed  Google Scholar 

  16. Xie L, Wu H, Shen M, Augsburger LL, Lyon RC, Khan MA, et al. Quality-by-design (QbD): effects of testing parameters and formulation variables on the segregation tendency of pharmaceutical powder measured by the ASTM D 6940-04 segregation tester. J Pharm Sci. 2008;97(10):4485–97.

    Article  CAS  PubMed  Google Scholar 

  17. Food and Drug Administration CDER. Guidance for industry, PAT—a framework for innovative pharmaceutical development, manufacturing, and quality assurance. 2006

  18. Saerens L, Dierickx L, Lenain B, Vervaet C, Remon JP, De Beer T. Raman spectroscopy for the in-line polymer–drug quantification and solid state characterization during a pharmaceutical hot-melt extrusion process. Eur J Pharm Biopharm. 2011;77(1):158–63.

    Article  CAS  PubMed  Google Scholar 

  19. Saerens L, Dierickx L, Quinten T, Adriaensens P, Carleer R, Vervaet C. In-line NIR spectroscopy for the understanding of polymer–drug interaction during pharmaceutical hot-melt extrusion. Eur J Pharm Biopharm. 2012;81(1):230–7.

    Article  CAS  PubMed  Google Scholar 

  20. De Beer T, Burggraeve A, Fonteyne M, Saerens L, Remon JP, Vervaet C. Near infrared and raman spectroscopy for the in-process monitoring of pharmaceutical production processes. Int J Pharm. 2011;417(1–2):32–47.

    Article  PubMed  Google Scholar 

  21. Kelly AL, Gough T, Dhumal RS, Halsey SA, Paradkar A. Monitoring ibuprofen–nicotinamide cocrystal formation during solvent free continuous cocrystallization (SFCC) using near infrared spectroscopy as a PAT tool. Int J Pharm. 2012;426(1–2):15–20.

    Article  CAS  PubMed  Google Scholar 

  22. Almeida A, Saerens L, De Beer T, Remon JP, Vervaet C. Up scaling and in-line process monitoring via spectroscopic techniques of ethylene vinyl acetate hot-melt extruded formulations. Int J Pharm. 2012;439(1–2):223–9.

    Article  CAS  PubMed  Google Scholar 

  23. Windbergs M, Strachan CJ, Kleinebudde P. Understanding the solid-state behaviour of triglyceride solid lipid extrudates and its influence on dissolution. Eur J Pharm Biopharm. 2009;71(1):80–7.

    Article  CAS  PubMed  Google Scholar 

  24. Windbergs M, Strachan CJ, Kleinebudde P. Influence of structural variations on drug release from lipid/polyethylene glycol matrices. Eur J Pharm Biopharm. 2009;37(5):555–62.

    CAS  Google Scholar 

  25. Rossi A, Savioli A, Bini M, Capsoni D, Massarotti V, Bettini R, et al. Solid-state characterization of paracetamol metastable polymorphs formed in binary mixtures with hydroxypropylmethylcellulose. Thermochim Acta. 2001;406:55–67.

    Article  Google Scholar 

  26. Qi S, Gryczke A, Belton P, Craig DQM. Characterisation of solid dispersions of paracetamol and EUDRAGIT® E prepared by hot-melt extrusion using thermal, microthermal and spectroscopic analysis. Int J Pharm. 2008;354:158–67.

    Article  CAS  PubMed  Google Scholar 

  27. Qi S, Avalle P, Saklatvala R, Craig DQM. An investigation into the effects of thermal history on the crystallisation behaviour of amorphous paracetamol. Eur J Pharm Biopharm. 2008;69:364–71.

    Article  CAS  PubMed  Google Scholar 

  28. Sweeney G. (thesis) Queen’s Belfast University 2012.

  29. Vithani K, Maniruzzaman M, Slipper IJ, Mostafa S, Miolane C, Cuppok Y, et al. Sustained release solid lipid matrices processed by hot-melt extrusion (HME). Colloids Surf B: Biointerfaces. 2013;110:403–10.

    Article  CAS  PubMed  Google Scholar 

  30. Haupt M, Thommes M, Heidenreich A, Breitkreutz J. Lipid-based intravesical drug delivery systems with controlled release of trospium chloride for the urinary bladder. J Control Rel. 2013;170:161–6.

    Article  CAS  Google Scholar 

Download references

Conflict of interest

Authors Islam, Maniruzzaman, Hasley, Chowdhry and Douroumis declare no conflict of interest.

Author information

Authors and Affiliations

  1. Faculty of Engineering and Science, University of Greenwich, Medway Campus, Chatham Maritime, Chatham, Kent, ME4 4TB, UK

    Muhammad T. Islam, Mohammed Maniruzzaman, Babur Z. Chowdhry & Dennis Douroumis

  2. ThermoFisher Scientific, Stafford House, Boundary Way, Hemel Hempstead, HP2 7GE, UK

    Sheelagh A. Halsey

Authors
  1. Muhammad T. Islam
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohammed Maniruzzaman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sheelagh A. Halsey
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Babur Z. Chowdhry
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dennis Douroumis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dennis Douroumis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Islam, M.T., Maniruzzaman, M., Halsey, S.A. et al. Development of sustained-release formulations processed by hot-melt extrusion by using a quality-by-design approach. Drug Deliv. and Transl. Res. 4, 377–387 (2014). https://doi.org/10.1007/s13346-014-0197-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13346-014-0197-8

Keywords

Search

Navigation